Among the six commonly used Japanese Kampo medicines that indicated cardiac effects in human and rodents investigated in this study, MBT was the only one that demonstrated inhibition of cardiac hypertrophy induced by AngII (Figure 2). The gene discussed is AGT; the disease is cardiac hypertrophy.